JP2011521663A5 - - Google Patents

Download PDF

Info

Publication number
JP2011521663A5
JP2011521663A5 JP2011512159A JP2011512159A JP2011521663A5 JP 2011521663 A5 JP2011521663 A5 JP 2011521663A5 JP 2011512159 A JP2011512159 A JP 2011512159A JP 2011512159 A JP2011512159 A JP 2011512159A JP 2011521663 A5 JP2011521663 A5 JP 2011521663A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011512159A
Other versions
JP2011521663A (ja
Filing date
Publication date
Priority claimed from ES200801682A external-priority patent/ES2330826B1/es
Application filed filed Critical
Publication of JP2011521663A publication Critical patent/JP2011521663A/ja
Publication of JP2011521663A5 publication Critical patent/JP2011521663A5/ja
Pending legal-status Critical Current

Links

JP2011512159A 2008-06-04 2009-06-01 高容量アデノウイルスをパッケージングするための系 Pending JP2011521663A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200801682A ES2330826B1 (es) 2008-06-04 2008-06-04 Sistema para empaquetamiento de adenovirus de alta capacidad.
ESP200801682 2008-06-04
PCT/ES2009/070194 WO2009147271A2 (es) 2008-06-04 2009-06-01 Sistema para empaquetamiento de adenovirus de alta capacidad

Publications (2)

Publication Number Publication Date
JP2011521663A JP2011521663A (ja) 2011-07-28
JP2011521663A5 true JP2011521663A5 (ja) 2012-01-05

Family

ID=41259582

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011512159A Pending JP2011521663A (ja) 2008-06-04 2009-06-01 高容量アデノウイルスをパッケージングするための系

Country Status (11)

Country Link
US (1) US20110081718A1 (ja)
EP (1) EP2298925B1 (ja)
JP (1) JP2011521663A (ja)
CN (1) CN102112616A (ja)
AU (1) AU2009254522A1 (ja)
BR (1) BRPI0913383A2 (ja)
CA (1) CA2727104A1 (ja)
ES (1) ES2330826B1 (ja)
MX (1) MX2010013365A (ja)
RU (1) RU2010154410A (ja)
WO (1) WO2009147271A2 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI702955B (zh) 2012-05-15 2020-09-01 澳大利亞商艾佛蘭屈澳洲私營有限公司 使用腺相關病毒(aav)sflt-1治療老年性黃斑部退化(amd)
EP2878674A1 (en) * 2013-11-28 2015-06-03 Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) Stable episomes based on non-integrative lentiviral vectors
KR102537394B1 (ko) 2014-03-17 2023-05-30 애드베룸 바이오테크놀로지스, 인코포레이티드 원추세포에서 증강된 유전자 발현을 위한 조성물 및 방법
MY187898A (en) 2015-03-02 2021-10-27 Adverum Biotechnologies Inc Compositions and methods for intravitreal delivery of polynucleotides to retinal cones
GB2545763A (en) 2015-12-23 2017-06-28 Adverum Biotechnologies Inc Mutant viral capsid libraries and related systems and methods
CA3136545A1 (en) * 2019-04-12 2020-10-15 Freeline Therapeutics Limited Plasmid system

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA92008A (en) 1904-04-28 1905-03-07 Josiah Byram Millet Submarine signalling
CA91355A (en) 1904-11-22 1905-02-07 John Jay Tonkin Steam boiler
CA92037A (en) 1904-11-25 1905-03-07 The Hooven, Owens, Rentchler Company Turbine bearings
WO1979000514A1 (en) 1978-01-18 1979-08-09 Chubb Electronics Ltd Cash registers
DE3688418T2 (de) 1985-02-13 1993-08-26 Scios Nova Inc Menschlicher metallothionein ii-promotor in saeugetierexpressionssystemen.
EP0910652B1 (en) 1996-04-05 2014-10-08 The Salk Institute For Biological Studies Hormone-mediated methods for modulating expression of exogenous genes in mammalian systems, and products related thereto
AU772630B2 (en) * 1999-01-14 2004-05-06 Novartis Ag Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use
WO2000049166A2 (en) * 1999-02-18 2000-08-24 Merck & Co., Inc. Production of helper dependent adenovirus vectors based on use of endonucleases
US6287813B1 (en) 1999-04-23 2001-09-11 Cistronics Cell Technology Gmbh Antibiotic-based gene regulation system
AU5451300A (en) * 1999-05-28 2000-12-18 Mount Sinai School Of Medicine, The A novel packaging cell line for the rescue, production and titration of high-capacity adenovirus amplicon vectors
US6750015B2 (en) 2000-06-28 2004-06-15 Kathryn B. Horwitz Progesterone receptor-regulated gene expression and methods related thereto
US20020064860A1 (en) 2000-11-29 2002-05-30 Schering Corporation Method for purifying adenoviruses
JP2004532039A (ja) * 2001-03-26 2004-10-21 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ ヘルパー依存性アデノウイルスベクター系およびその系の使用方法
DE10148294C1 (de) 2001-09-29 2003-01-16 Unicor Rohrsysteme Gmbh Formbackenhälfte für einen Corrugator zum Herstellen von Querrippenrohren
WO2003093293A2 (en) 2002-04-29 2003-11-13 Saint Louis University Peptide antagonists of tgf-beta family members and therapeutic uses thereof
ES2304069B1 (es) 2003-08-22 2009-08-12 Proyecto De Biomedicina Cima, S.L. Peptidos con capacidad de unirse al factor transformante de crecimiento beta 1 (tgf-b1).
WO2007059473A2 (en) 2005-11-12 2007-05-24 Introgen Therapeutics, Inc. Methods for the production and purification of adenoviral vectors

Similar Documents

Publication Publication Date Title
BE2015C040I2 (ja)
BRPI0925311A2 (ja)
BR112012008195A2 (ja)
BR112012003062A2 (ja)
BRPI0924307A2 (ja)
BR112012008267A2 (ja)
BR112012012396A2 (ja)
BR112012000607A2 (ja)
BR122021004633A2 (ja)
BR112012000665A2 (ja)
BR112012012487A2 (ja)
BR112012003080A2 (ja)
BR122017024704A2 (ja)
BR112012003853A2 (ja)
BR112012012080A2 (ja)
BRPI0924534A2 (ja)
BR112012009797A2 (ja)
BR112012009446A2 (ja)
BRPI1005795A2 (ja)
BR112012010357A2 (ja)
BR112012007656A2 (ja)
BR112012001263A2 (ja)
BR122019005883A2 (ja)
BR112012000159A2 (ja)
BR112012014856A2 (ja)